Note : We Will Not Share Your Information To Any Third Parties.
NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
---|---|---|---|---|---|---|
6505-01-480-6901 Item PartTypeName: FUROSEMIDE INJECTION | 6505 | 014806901 | M | P | ||
CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
U | A | |||||
Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
NDC00409-1639-10 | 2 | 2 | 3 |
MRC | Criteria | Characteristic |
---|---|---|
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 10.000 MILLIGRAMS FUROSEMIDE PER MILLILITER |
CBBL | FEATURES PROVIDED | STERILE |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 10.000 MILLILITERS |
CSGS | ADMINISTRATION | INTRAPERITONEAL OR INTRAVENOUS |
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | FUROSEMIDE INJECTION USP 10MG/ML STERILE 10ML SYRINGE 10'S |
SUPP | SUPPLEMENTARY FEATURES | ANSYR PLASTIC SYRINGE MOLDED FROM SPECIALLY FORMULATED POLYPROPYLENE |
AKJQ | PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
CQCT | PRIMARY CONTAINER TYPE | SYRINGE |
CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 10 |
FEAT | SPECIAL FEATURES | CONTAINS NO PRESERVATIVES; STORE AT CONTROLLED ROOM TEMP 15 TO 30 DEG C; PROTECT FROM LIGHT; FOR TX OF EDEMA ASSOCIATED WITH CONGESTIVE HEART FAILURE, CIRRHOSIS OF THE LIVER AND RENAL DISEASE, INCLUDING NEPHROTIC SYNDROME |
Guaranteed on-time |
|
Customized and |
|
Over 5100 |
|
Complete Purchasing |